Investor Relations

CUTTING-EDGE CARDIAC CARE

Miracor Medical Systems is developing and commercializing a unique and potentially disruptive therapy for patients with impaired cardiac function. PiCSO® (Pressure-controlled Intermittent Coronary Sinus Occlusion) is designed to improve clinical outcome in patients presenting with Acute Coronary Syndrome or Heart Failure.

Miracor has won several innovation awards and completed two financing rounds raising a double-digit Million Euro amount in venture capital and public funding.

For further information please contact:

  • Olivier Delporte
  • Managing Director
  • Email odelporte[at]miracormedical.com

MTIL15_win